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Predatory marine cone snails (genus Conus) utilize complex
venoms mainly composed of small peptide toxins that target
voltage- and ligand-gated ion channels in their prey. Although
the venoms of a number of cone snail species have been inten-
sively profiled and functionally characterized, nothing is known
about the initiation of venom expression at an early develop-
mental stage. Here, we report on the expression of venom
mRNA in embryos of Conus victoriae and the identification of
novel - and O-conotoxin sequences. Embryonic toxin mRNA
expression is initiated well before differentiation of the venom
gland, the organ of venom biosynthesis. Structural and func-
tional studies revealed that the embryonic-conotoxins exhibit
the same basic three-dimensional structure as the most abun-
dant adult toxin but significantly differ in their neurological
targets. Based on these findings, we postulate that the venom
repertoire of cone snails undergoes ontogenetic changes
most likely reflecting differences in the biotic interactions of
these animals with their prey, predators, or competitors. To
our knowledge, this is the first study to show toxin mRNA
transcripts in embryos, a finding that extends our under-
standing of the early onset of venom expression in animals
and may suggest alternative functions of peptide toxins dur-
ing development.
Cone snails of the genus Conus are predatory marine gastro-
pods that utilize venom to capture prey. Conus venoms mainly
consist of small disulfide-rich peptides commonly referred to as
conotoxins or conopeptides. Each of the 700 Conus species
synthesizes its own characteristic repertoire of toxic peptides. It
has been estimated that the toxin repertoire of cone snails com-
prises 100,000 different bioactive compounds with various
neurological targets (1). Remarkably, this vast library of bioac-
tive peptides has been generated by a relatively small number of
gene superfamilies (2, 3). Conotoxins are translated as precur-
sor proteins with an N-terminal signal sequence, an intermedi-
ate pro-region followed by the mature toxin at the C terminus.
Comparisons between the different gene superfamilies revealed
high conservation within the primary amino acid sequence for
the signal and pro-sequence, whereas the mature toxin region
exhibits hypermutation between a conserved disulfide scaffold
(2). The venom repertoire of cone snails is further extended
through the addition of post-translational modifications that
increase toxin potency (4, 5) and aid in stabilizing the three-
dimensional structure of the molecule (6, 7). Such is the diver-
sification of conotoxins that venom profiles differ significantly
among individuals of the same species (8–10). The exactmech-
anismunderlying the accelerated evolution of conotoxins is not
yet understood, but it has been suggested that rapid genetic
divergence is driven by the various interactions between the
toxins and the snail’s biotic environment. Besides their function
in predation, anecdotal evidence points to the role for conotox-
ins in deterring predators and competitors (2, 11). Given the
diversity of disulfide-rich peptides in Conus, other functions,
such as regulation of social behavior as observed in other mol-
luscs (12, 13), may exist in this genus.
Very little is known about the onset of venom synthesis in
cone snails. Female cone snails typically lay their eggs in egg
capsules attached to a benthic substrate. Prehatching time,
hatching size, and total prejuvenile development greatly vary
betweendifferentConus species anddepend to a large extent on
the presence or absence of a feeding larval stage (14–17).
The few studies addressing feeding behavior of juvenile
snails indicate that predation can occur a few days after lar-
val metamorphosis (18), suggesting initialization of venom
biosynthesis at an earlier developmental stage. Although
juveniles of Conus textile were shown to feed on the same
prey as adults (18), specimens of Conus magus exhibited a
change in prey type from polychaetes to fish as they matured
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(19). Whether the venom composition changed during this
transition was not determined.
Among themost extensively studied cone snail toxins are the
-conotoxins, known antagonists of the nicotinic acetylcholine
receptors (nAChRs)4 (20–22). Recent studies have also identi-
fied N-type calcium channels as another neuronal target for a
number of -conotoxins (23, 24). -Conotoxins inhibit these
channels via activation of the GABAB receptor (24) and target
these receptors and ion channels with exquisite selectivity. Tar-
get specificity not only varies between toxins from different
Conus species but, remarkably, even between peptides isolated
from the same individual (25). It is likely that the expression
profile of -conotoxins exhibiting different target specificity
reflects an adaptation to the biotic environment.
In this study, we demonstrate that prior to hatching, embryos
of Conus victoriae are capable of expressing venom mRNA.
Interestingly, embryonic - and O-conotoxin sequences differ
significantly from adult toxin transcripts. Embryonic -cono-
toxins were chosen for further characterization. Although the
novel embryonic -conotoxin Vc1.2 shares the same three-di-
mensional structure of the previously reported adult toxin
Vc1.1, these peptides exhibit different affinities for the GABAB
receptor/N-type Ca2 channels and distinct subtype selectivi-
ties for the nAChR. Despite thorough electrophysiological
investigations, the target receptor for a second embryonic
toxin, Vc1.3, could not be determined, suggesting a novel target
for this particular venom species. It appears that cone snails at
different developmental stages differ in the relative abundance
of their bioactive peptides potentially reflecting their particular
ontogenetic stage.
EXPERIMENTAL PROCEDURES
Specimen Collection and Histological Preparation—Speci-
mens ofC. victoriaewere collected fromBroome,WesternAus-
tralia, maintained in flow-through seawater tanks at 24 °C, and
fed every 2 weeks with live specimens of Austrocochlea spp.
Approximately 4 weeks post-collection, two specimens of C.
victoriae laid egg capsules, each containing between 20 and 50
eggs derived from two independent matings. For histological
preparations, adult snails were transferred to seawater
containing 2% MgCl2 for 4 h followed by overnight fixation in
4% paraformaldehyde/phosphate-buffered saline (PBS). Speci-
mens were washed in water for 15min, decalcified for 5 h in 5%
formic acid, and stored in 70% ethanol until further processing.
Embryos from two specimens of C. victoriae were removed
from their egg capsules 18 days after egg deposition and fixed in
4% paraformaldehyde/PBS. Embryos were sequentially washed
in PBS and embedded in 2% agarose/PBS preheated to 60 °C.
Once set, the agarose blocks were stored in 70% ethanol until
further processing. Adult snails and embryos were processed,
sectioned (7 m), and stained with Mallory’s trichrome stain
(26) following routine histological procedures.
Conotoxin cDNA Isolation and Sequencing—Venom ducts
were dissected and embryos collected from two adult speci-
mens of C. victoriae 18 days after egg deposition, immediately
snap-frozen in liquid nitrogen, and stored at 80 °C. The two
sets of embryos represent the progeny of two independentmat-
ing events. Frozen embryos and venom duct tissues were
ground under liquid nitrogen. Total RNA was extracted using
TRIzol reagent (Invitrogen), and DNase I was treated with
TurboDNase (Ambion). RNA extraction andDNase treatment
were performed according to the manufacturer’s instructions.
Total RNA concentrations were determined using a spectro-
photometer, and RNA integrity was verified by gel electropho-
resis. cDNA was reverse-transcribed from 720 ng of DNase-
treated RNA using the transcriptor high fidelity cDNA
synthesis kit (Roche Applied Science). Primary reverse tran-
scription PCRs (RT-PCR) were performed in volumes of 30 l
containing 2 l of cDNA (60 ng), 0.3 l of TITANIUM
TaqDNA polymerase (Clontech), 1 Advantage 2 PCR buffer
(Clontech), 200 M of each deoxynucleotide triphosphate
(dNTPs), and 0.2 M of forward and reverse oligonucleotides
(supplemental Table 1). PCR cycle conditions were 1 cycle at
94 °C for 3 min and 30 cycles at 94 °C, 54 °C for 30 s and 72 °C
for 30 s, and then 72 °C for 10 min. To rule out false amplifica-
tion of genomicDNA, a negative control was performed using a
reverse transcription reaction from which the enzyme reverse
transcriptase was excluded. Nested PCRs were performed as
described above except 2l of the 1:5 diluted primary PCR was
used as DNA template, and oligonucleotides were replaced
with 0.2 M of nested oligonucleotides (supplemental Table 1),
and the annealing temperaturewas reduced to 43 °C for 30 s.All
PCR amplicons were analyzed by gel electrophoresis, cloned
into pGEM-T plasmid vectors (Promega), and subsequently
sequenced as described previously (27). All sequences analyzed
in this study were deposited in GenBankTM (National Center
for Biotechnology Information, National Library of Medicine,
Bethesda). Nucleotide sequences were translated into the pre-
dicted amino acid residues, and comparative alignments of the
protein and nucleotide sequences were performed using
MAFFTE-INS-i sequence alignment bymeans of local pairwise
alignment information (28). The putative signal peptides were
predicted using SignalP software (29).
Peptide Synthesis—The embryonic peptides Vc1.2 and Vc1.3
were synthesized using Fmoc (N-(9-fluorenyl)methoxycar-
bonyl) solid-phase peptide chemistry (Liberty peptide synthe-
sizer, CEM Corp.). Peptides were cleaved from the solid-phase
resin with TFA/H2O/triisopropylsilane/3,6-dioxa-1,8-octane-
dithiol (90:2.5:2.5:5) for 2 h. The crude peptideswere isolated by
ether precipitation, dissolved 30:70, v/v, in ACN/H2O, lyophi-
lized, and purified on aC18 column (5-mparticle size, dimen-
sions are 15 cm 4.6mm,DiscoveryC18 column, Supelco Inc.)
using an Agilent 1200 HPLC system (Agilent) with a linear gra-
dient from 10 to 60% buffer B (99% ACN, 0.1% TFA; buffer A,
0.1% TFA) over 30 min. The purified linear peptides were oxi-
dized in 100 mM NH4HCO3 in water/ACN (v/v, 90:10%) at a
concentration of 0.5 mg/ml for 16 h at room temperature. Oxi-
dized peptides were isolated to a final purity of94% on a C18
column (5-m particle size, dimensions: 9.4 cm  2.5 mm,
Eclipse C18 column, Agilent) using an Agilent 1100 HPLC sys-
tem with the gradient described above. The identities of the
fully oxidized peptides were confirmed by high resolutionmass
4 The abbreviations used are: nAChR, nicotinic acetylcholine receptor; ACN,
acetonitrile; HVA, high voltage-activated; DRG, dorsal root ganglion; ACh,
acetylcholine.
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spectrometry (6510 Q-TOF LC/MS mass spectrometer,
Agilent).
Electrophysiological Studies on Embryonic Peptides—RNA
preparation, oocyte preparation, and expression of nAChR
subunits in Xenopus oocytes were performed as described
previously (30). Briefly, plasmids with cDNA encoding the
rat 3, 4, 9, 10, 2, and 4 nAChR and human 7 sub-
units were subcloned into the oocyte expression vector
pNKS2 and were used for mRNA preparation using
mMESSAGE mMACHINE kit (Ambion Inc.). All oocytes
were injected with 5 ng of cRNA and then kept at 18 °C in
ND96 buffer (96 mM NaCl, 2 mM KCl, 1 mM CaCl2, 1 mM
MgCl2, and 5 mM HEPES, pH 7.4) supplemented with 50
mg/liter gentamycin and 5 mM pyruvic acid 2–5 days before
recording. Membrane currents were recorded from Xenopus
oocytes using an automated work station with eight channels
in parallel, including drug delivery and on-line analysis
(OpusXpress 6000A work station; Molecular Devices Inc.)
and a two-electrode virtual ground voltage clamp circuit
with a GeneClamp 500B amplifier (Molecular Devices). Both
the voltage recording and current injecting electrodes were
pulled from borosilicate glass (GC150T-15, Harvard Appa-
ratus Ltd.) and had resistances of 0.2–1.5 megohms when
filled with 3 M KCl. All recordings were conducted at room
temperature (20–23 °C) using a bath solution of ND96 as
described above. During recordings, the oocytes were per-
fused continuously at a rate of 1.5 ml/min, with 300-s incu-
bation times for the conotoxin. Acetylcholine (100 mM for
7, 30 mM for all other nAChR subtypes) was applied for 2 s
at 5 ml/min, with 300-s washout periods between applica-
tions. Cells were voltage-clamped at a holding potential of
80 mV. Data were sampled at 500 Hz and filtered at 50 Hz.
Peak current amplitude was measured before and following
incubation of the peptide (31).
Concentration-response curves for antagonists were fitted
by unweighted nonlinear regression to the logistic equation,
Ex  Emax XnH/(XnH  IC50nH), where Ex is the response; X is
the antagonist concentration;Emax is themaximal response, nH
is the slope factor, and IC50 is the concentration of antagonist
that inhibits the agonist response by 50%. All electrophysiologi-
cal data were pooled (n 4–8 for each data point) and repre-
sent the means  S.E. of the fit. Computation was carried out
using SigmaPlot 11.0 (Systat Software).
Dorsal root ganglion (DRG) neurons were enzymatically dis-
sociated from ganglia of 7–14-day-oldWistar rats according to
standard protocols as described previously (24). The external
recording solution contained 150 mM tetraethylammonium
chloride, 2 mM BaCl2, 10 mM D-glucose, 10 mM HEPES, pH
7.3–7.4. Patch recording electrodes were filled with an internal
solution containing 140 mM CsCl, 1 mMMgCl2, 5 mMMgATP,
0.1 mM NaGTP, 5 mM 1,2-bis(2-aminophenoxy)ethane-
N,N,N,N-tetraacetic acid-Cs4, 10 mM HEPES, pH 7.3, with
CsOH and had resistances of 1.0–2.5 megohms. Membrane
currents were recorded using the whole-cell configuration of
the patch clamp technique with an Axopatch 200B amplifier
(Molecular Devices). A voltage protocol using step depolariza-
tions from 80 to 10 mV was applied when examining high
voltage-activated (HVA) calciumchannel currentswithBa2 as
the charge carrier. Test potentials 150 ms in duration were
applied every 20 s. Leak and capacitative currents were sub-
tracted using aP/4 pulse protocol. Membrane currents were
acquired by a computer using pClamp 9.2 software (Molecular
Devices), filtered at 2 kHz, and sampled at 8 kHz by theDigidata
1322A (Molecular Devices). Sampled data were stored digitally
on a computer for further analysis.
NMR Spectroscopy and Structure Calculations—NMR ex-
perimentswere performed at 25 °C on a 1.5mMVc1.2 sample in
95% H2O, 5% 2H2O, pH 3.6. Two-dimensional homonuclear
TOCSY spectra, with a spin-lock time of 70 ms, and double
quantum filtered correlated spectroscopy spectra were
acquired on a DRX-600 spectrometer equipped with a triple
resonance probe. Two-dimensional NOESY spectra with a
mixing time of 250ms, 15NHSQC, and 13CHSQC spectra were
recorded on an Avance-800 spectrometer equipped with a TCI
cryoprobe. Spectra were processed using TOPSPIN version 1.3
(Bruker Biospin Pty. Ltd.) and analyzed using XEASY (32).
Backbone and side chain 1H, 13C, and 15N chemical shifts were
assigned. NOEs were assigned automatically using CYANA 2.1
(33, 34). The f and y angle constraints were predicted using
TALOS (35) based on chemical shifts and were used in struc-
ture calculations when the predictions were consistent with an
analysis of 3JHNHa coupling constants based ondouble quantum
filtered-COSY spectra.
A family of 200 structures was calculated using Xplor-NIH
(36) using standard simulation annealing scripts. The 80
lowest energy structures were then subject to energy mini-
mization in water; during this process, a box of water with a
periodic boundary of 18.856 Å was built around the peptide
structure, and the ensemble was energy-minimized on the
basis of NOE and dihedral constraints and the geometry of
the bonds, angles, and impropers (37). From this set of struc-
tures, a final family of 20 lowest energy structures was cho-
sen for analysis using PROCHK-NMR (38) and MOLMOL
(39). The final structures had no experimental distance vio-
lations greater than 0.2 Å or dihedral angle violations greater
the 5°. The final structures and the associated structural con-
straints have been deposited in the BioMagResBank (40)
under accession number 20126.
Protein Extraction and Mass Spectrometric Analyses—Venom
ducts were dissected from four snails, and crude venom was
manually squeezed from the ducts and air-dried. Approxi-
mately 1mg of venomwas reconstituted in 1ml of ice-cold 30%
ACN, 0.3% trifluoroacetic acid (TFA) followed by sonication
for 10 min on ice. The extracts were centrifuged at 13,000  g
for 20min; the supernatants were lyophilized and reconstituted
in 500 l of ultrapure water. Because of the complexity of the
venom samples, extracts were separated by reversed-phase
HPLC on amicropreparative C18 column (3.5mparticle size,
dimensions: 2.1  100 mm, X-Bridge, Waters) prior to mass
spectrometric analysis using a linear gradient from 10 to 60%
buffer B (95%ACN, 0.1%TFA; bufferA, 0.1%TFA) over 70min.
Reversed-phase venom fractions were individually analyzed on
a MALDI-TOF mass spectrometer (QSTAR Pulsar, positive
reflector mode, AB SCIEX). In addition to MALDI-TOF MS,
venom extracts were analyzed by electrospray ionization-MS/
MS. Samples were loaded onto a C18 reversed-phase column
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(ProtoCol nano column, particle size 300 Å and 3 m, dimen-
sions 75 m  100 mm, SGE Analytical Sciences) and ana-
lyzed using a Hybrid Quadrupole-TOF LC/MS/MS mass
spectrometer (QSTAR Elite, AB SCIEX). Solvent A con-
tained 0.1% formic acid, and solvent B consisted of 95%
ACN, 0.1% formic acid. Separation was performed with a
solvent B gradient of 5–60% over 90 min, followed by
60–80% B over 10 min. Acquired data were analyzed manually
using Analyst QS software (version 2.0, AB SCIEX) accounting
for the presence of various post-translationally modified
peptide precursors (e.g. sulfation of tyrosines, -carboxylation
of glutamate, hydroxylation of proline, and C-terminal
amidation).
RESULTS
Identification of Novel Conotoxin Transcripts in C. victoriae
Embryos—RT-PCR using universal - (41–43) and O-cono-
toxin (44) oligonucleotides led to the discovery of a number of
novel toxinmRNA transcripts expressed in embryos and adults
of C. victoriae and confirmed the presence of -conotoxin
Vc1.1mRNA in the venomduct of adult specimens (Fig. 1) (43).
All novel sequences were named according to the nomencla-
FIGURE 1. A, universal - and O-conotoxin RT-PCR showing toxin mRNA expression in embryos (n 2, each pooled from50 embryos) and adult specimens
(n 2) of C. victoriae. 110 ng of cDNA was amplified using three - (-1, -2, and -3) and one O-conotoxin (O-1) oligonucleotide pair. Ferritin (Fer) served as
a reference gene. No reverse transcriptase controls (nRT) were performed to rule out contamination by genomic DNA. RT-PCRswere subsequently cloned and
subjected to nucleotide sequencing. Bars represent the number of clones identified per RT-PCR expressed as percentages. DNA ladder: 1 kb plus (Invitrogen).
*, analogue of Vc1.1 carrying one amino acid substitution. B, conotoxin sequences identified by RT-PCR showing the predicted signal peptide sequences
(underlined), the spacer region, and themature toxin region highlighted in gray. The number of clones sequenced per replicate (n 2) is given in parentheses
(43). GenBankTM accession numbers are as follows: Vc1.2, GU046308; Vc1.3, GU046309; Vc6.7, JF433900; Vc6.8, JF433901; Vc6.9, JF433902; Vc6.10, JF433903;
Vc6.11, JF433904; Vc6.12, JF433905; Vc6.13, JF433906; Vc6.14, JF433907; Vc6.15, JF433908; Vc6.16, JF433909; and Vc6.1, JF433910.
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ture previously used forC. victoriae venom peptides, where the
first two letters indicate the species, the following number (1 or
6) represents the toxin family ( or O), and the last number
implies the order of toxin discovery (e.g. Vc1.2 is the second
-conotoxin identified for C. victoriae) (45).
A total of five adult-specific and six embryo-specific O-su-
perfamily toxins were identified, with no sequence overlap
between these two life stages (Fig. 1B). Interestingly, the
O-conotoxin expression pattern was nearly identical between
the two sets of embryos tested with the exception of Vc6.15
which was only identified in one set of embryos (Fig. 1B). The
most abundant transcript was Vc6.12 (47% of cloned
sequences) in adults and Vc6.17 (54%) in embryos. O-super-
family toxins exhibit a characteristic pattern of 6 cysteines
(C-C-CC-C-C) that form three disulfide bonds. Members of
this family are known modulators of voltage-sensitive calcium,
potassium, and sodium channels (44, 46). Alignment of the
novel O-conotoxins with other members of the O-superfamily
revealed high sequence similarity to the O2 gene superfamily
(Fig. 2B), peptides with an as yet unidentified target receptor
(44, 47).
Universal -conotoxin RT-PCR identified two novel tran-
scripts in the embryos (Vc1.2 and Vc1.3; Fig. 1) and confirmed
the presence of Vc1.1 in the adults (43). Interestingly, utilizing a
number of different universal -conotoxin oligonucleotides
(-1, -2, and -3; Fig. 1) did not lead to the identification of
additional sequences suggesting that these toxins represent the
most abundant -conotoxin transcripts. In the adult, all but
one clone (Vc1.1*) represented Vc1.1 (Fig. 1B). This finding is
consistent with previous studies addressing -conotoxin
expression in C. victoriae (43, 45). The two cDNA transcripts
identified from the embryos were almost equally represented
with 55% for Vc1.2 and 45% for Vc1.3 using the -1 oligonu-
cleotide and slightly higher percentages for Vc1.2 (75%) when
using the -2 oligonucleotide (Fig. 1). The frequency of
sequences obtained by RT-PCR screening generally indicates
relative abundances of mRNA transcripts (48, 49). Thus, based
on the number of clones obtained by primary RT-PCR analyses,
relative abundances of toxinmRNAs varied greatly between the
two life stages tested. The presence of such a limited yet distinct
number of -conotoxin transcripts was intriguing and was
therefore further investigated.
Embryonic and Adult -Conotoxin Repertoire of C. victoriae—
To further investigate -conotoxin expression in adult versus
embryos, toxin-specific oligonucleotides were designed for
Vc1.1 and Vc1.2 (supplemental Table 1). Sequence similarities
among the three transcripts precluded the design of specific
PCR oligonucleotides for Vc1.3. Nested PCR can be utilized to
detect low abundant transcripts andwas performed on primary
-conotoxin PCRs using internal toxin-specific oligonucleo-
FIGURE2.Comparativealignmentofnovelembryonic- (A) andO-conotoxins (B) isolated fromC.victoriaewith toxinsequences fromotherconesnail
species.Alignmentwas performedusingMAFFT E-INS-i sequence alignment bymeans of local pairwise alignment information (28). Sequences obtained from
C. victoriae embryos and adults are highlighted blue and orange, respectively. Predicted protein signal sequences are underlined (SignalP). Conserved cysteine
residues are shown in boldface, and the predicted mature toxin regions are highlighted gray (50). Basic and acidic amino acids are shown in blue and red,
respectively. Dashes denote gaps. Amino acid conservations are denoted by an asterisk, and colons and periods represent a high and low degree of similarity,
respectively.
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tides. Amplicons were successfully generated demonstrating
that embryos express mRNA encoding the adult toxin Vc1.1
and that adults possess mRNA for the embryonic toxin Vc1.2
(supplemental Fig. 1).
Sequence Alignment of Novel Embryonic Toxins—Alignment
of the novel embryonic toxin peptides with available -cono-
toxin sequences revealed high similarity of the novel peptides to
-conotoxins sharing the conserved 4/7 cysteine pattern with 4
residues between C1 and C2, and 7 residues between C3 and C4
(Fig. 2). The predicted signal sequences and pro-regions share
100% identity although differences in the mature toxin regions
are apparent. Based onobservationsmade for other conotoxins,
further proteolytic C-terminal cleavage and subsequent amida-
tion of -CGRRR- to -C-NH2- are likely to occur (50). Interest-
ingly, protein alignment revealed the highest similarity of the
pro-region and themature toxin region between the embryonic
peptides and -conotoxin PnIB from Conus pennaceus, a
potent inhibitor of the 7 subtype of the nAChR (51), although
the adult toxin Vc1.1 is a known antagonist of the 910 sub-
type (52). To further elucidate potential differences in the neu-
ronal target, electrophysiology was performed.
Determination of the Neuronal Target Receptor—The effects
of Vc1.2 and Vc1.3 were examined on ACh-evoked currents
mediated by various nAChR subtypes expressed in Xenopus
oocytes. ACh (30–100 mM) was applied at 5-min intervals, and
the peak amplitude of the corresponding membrane current
was assessed. The peptide was applied 5 min prior to co-appli-
cation of ACh plus peptide. Vc1.2 (1 mM) completely inhibited
ACh-evoked currentsmediated by32 nAChRs and inhibited
the ACh-evoked current amplitude mediated by 7 and 910
nAChRs by 54  5 and 46  4% (n  3–5), respectively (Fig.
3A). In contrast, Vc1.2 did not inhibit the 34, 42, or 44
nAChR subtypes (n 3–5) (Fig. 3A). Vc1.3 (1mM) exhibited no
significant activity at any of the neuronal nAChR subtypes (Fig.
3A). Concentration-response curves obtained for Vc1.2 dis-
played the following order of selectivity and corresponding IC50
values:32 (75 5 nM)7 (637 90 nM)910 (1mM)
(Fig. 3, B and E). These data indicate that Vc1.2 selectively and
potently targets the 32 and to a lesser extent the 7 nAChR
subtype. The embryonic toxin Vc1.2 therefore exhibits a dis-
tinct nAChR selectivity to the adult toxin Vc.1.1 (Fig. 3E).
Vc1.1 has previously been shown to inhibit N-type (CaV2.2)
Ca2 channel currents via activation of the G protein-coupled
GABAB receptor in sensory neurons (24). Therefore, the activ-
ity of Vc1.2 and Vc1.3 was also examined on depolarization-
activated whole-cell Ba2 currents in rat DRG neurons. Appli-
cation of Vc1.2 inhibited HVACa2 channel currents by 30.3%
at 100 nM (n 9) (Fig. 3, C–E). Vc1.3 was not active at 100 nM
and inhibited the Ba2 current amplitude by	20% at 1M (n
7) (Fig. 3, C–E). Both embryonic peptides Vc1.2 and Vc1.3
exhibit a reduced potency for GABAB receptor-mediated inhi-
bition of HVA Ca2 channel currents compared with Vc1.1
(Fig. 3E).
Structure Determination of Vc1.2—To investigate whether
subtype selectivity for the nAChR and affinity toward the
GABAB receptor arise from a difference in the three-dimen-
sional structures of the peptides, the solution structure of Vc1.2
was determined using nuclear magnetic resonance (NMR)
spectroscopy. As can be seen in the one-dimensional 1H NMR
spectra recorded at different pH values and temperatures (sup-
plemental Fig. 2), the backbone amide proton peak of Cys2 was
visible at pH 3.2 but not at pH 5.5 because of the exchange of
solvent water; other peaks did not shift appreciably over the pH
range 3.2–5.5, consistent with the fact that Vc1.2 does not con-
tain charged residues and indicating that the structure is main-
tained over this pH range. A summary of experimental con-
straints and structural statistics for Vc1.2 is given in Table 1.
The final 20 structures (Fig. 4A) fit well with experimentally
derived distance and angle constraints and arewell defined over
the entire length of the polypeptide. The closest-to-average
structure of Vc1.2 (Fig. 4B) is characterized by an -helix (res-
idues 6–11), as was also seen in other -conotoxins with the
same loop I and loop II lengths, such as Vc1.1 (30) and PnIA
(53). The N-terminal residues 2–4 also appear to form a 310
helix-like turn structure. The trans orientations of the peptide
bond preceding both Pro6 and Pro3 were established by the
intense H–H nuclear Overhauser effects (NOEs) between
the prolines and their preceding residues. Superposition of the
backbone heavy atoms (N, C, and C) of the final ensemble of
20 Vc1.2 structures with those of Vc1.1 (30) gave average group
root-mean-square deviation values of 0.66 Å, a value no larger
than the root-mean-square deviation within the Vc1.2 family,
indicating that the backbone structures are highly conserved in
these -conotoxins. Therefore, the different subtype specifici-
ties of Vc1.2 and Vc1.1 for nAChR binding must arise from the
specific amino acid side chain differences in these toxins.
Amino acid residues affecting the affinity of Vc1.1 for the
910 subtype were determined by scanningmutagenesis (54).
Vc1.2 differs from Vc1.1 in only four of those residues (Asp5,
Arg7, Asp11, and His12, see Figs. 4C and 5). Based on high
sequence similarities between Vc1.2 and Vc1.3, it is anticipated
that the two embryonic toxins share the same structure. The
additional Pro7 in Vc1.3 is unlikely to affect the -helical struc-
ture as demonstrated by comparing the solution structure of
Vc1.2 with that of PnIA, an -conotoxin with Pro6 and Pro7 in
the first loop (supplemental Fig. 3). Therefore, differences in
their ability to mediate GABAB receptor/N-type Ca2 channel
inhibition are likely to arise from specific side chain differences
(Pro7, Ile9, Ala10, and Leu15 in Vc1.3, see Fig. 5). Likewise, Vc1.3
differs from Vc1.2 in only three side chains important for 32
and 7 binding (Asn5, Ile9, and Leu15 in Vc1.3 (51, 55)) indicat-
ing that changes in these side chains may abolish binding to
these nAChR subtypes (Fig. 5).
Comparative Anatomy of the Embryonic and Adult Foregut—
Regions of the foregut important for venom biosynthesis,
transport, and delivery were identified in adult specimens of C.
victoriae (Fig. 6A). The venom apparatus consists of a long con-
voluted venom duct for toxin biosynthesis, a muscular venom
bulb believed to be involved in venom transport (56), and har-
poon-like radula teeth responsible for injecting the venom into
the prey (Fig. 6,A andC) (57). Toxin biosynthesis and potential
post-translational modifications take place in the columnar
epithelial layer of the venom duct (58). Following biosynthesis,
the venom is packed into ovoid-shaped granules that are
densely packed into larger circular vesicles upon secretion from
the epithelial cells (58). Histological examination of the em-
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bryos revealed that at the time when embryos of C. victoriae
were sampled and fixed for sectioning, they did not possess the
characteristic features of a functional venom apparatus.
Although the radula sac could be resolved in histological sec-
tions (Fig. 6B, panel iv), the proboscis and venom duct were not
yet differentiated. The venom duct in Conus is believed to
develop from an outpocketing of the mid-esophageal wall (15);
however, this differentiation could not be observed in any of the
embryonic specimens examined.
Mass Spectrometric Analysis of Venom Peptide Preparations—
Liquid chromatography coupled with mass spectrometry (LC/
MS) revealed a complex composition of C. victoriae venom
(supplemental Fig. 4A). Although the presence of multiple ana-
logues of Vc1.1 containing hydroxyproline and/or -carboxy-
glutamate was confirmed in this complexmixture (supplemen-
tal Fig. 4B (45, 59)), novel embryonic -conotoxins were not
detected in the adult’s venom despite extensive and targeted
LC-MS/MS analysis for various candidate venom peptide pre-
cursors. This finding indicates that although adults express
embryonic toxin mRNAs, minimal or no translation into bio-
active peptides takes place. Alternatively, the translated pep-
tides may have been present in the venom but could not be
detected using LC/MS due to unanticipated post-translational
modifications.Analyses of LC/MSdata obtained forC. victoriae
FIGURE3.Vc1.2andVc1. 3 inhibitionofnAChRsexpressed inXenopusoocytesandCa2 channel currents in ratDRGneurons.A, bar graphof the relative
inhibition of nAChRs expressed in Xenopus oocytes by 1 M Vc1.2 and Vc1.3. Vc1.2 (1 M) completely inhibited 32 nAChRs and inhibited 7 and 910 by
54and45%, respectively. Vc1.3was inactive at all neuronal nAChRsubtypes.B, concentration-response curvesobtained forVc1.2 inhibitionofnAChRsubtypes.
Vc1.2 wasmost active at32 nAChRs with an IC50 of 75 5 nM (Œ; n 3), 637 90 nM for7 (F; n 4–6), and1M for910 (f; n 3). C, superimposed
depolarization-activated whole-cell Ba2 currents elicited by voltage steps from a holding potential of80 to10mV in the absence (control) and presence
of 100 nM Vc1.2 (panel i) and 100 nM Vc1.3 (panel ii), respectively.D, bar graph of the relative inhibition of HVACa2 channel currents in rat DRG neurons by 100
nM and 1 M Vc1.2 and Vc1.3. Numbers in parentheses reflect number of cells. E, comparison of the IC50 values of Vc1.1, Vc1.2, and Vc1.3 at different nAChR
subtypes and percentage inhibition of calcium currents in isolated DRG neurons. Values determined in this study representmean S.E. * indicatesmean plus
95% confidence interval (54), and # represents mean S.E. (24).
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venom anticipated disulfide bond formation, C-terminal ami-
dation, hydroxylation of prolines, and -carboxylation of gluta-
mate as well as differential C- and N-terminal cleavage. Elec-
trospray ionization-MS/MS on the hybrid quadrupole-TOF
mass spectrometer (QSTARElite, ABSCIEX) is highly sensitive
allowing for the detection of peptides in the sub-femtomole
range. Thus, failure to identify Vc1.2 and Vc1.3 in the venom of
C. victoriae is unlikely to reflect the sensitivity of the detection
method used.
DISCUSSION
Molecular sequencing revealed venom mRNA expression in
embryos ofC. victoriae and led to the identification of five novel
O- and two -conotoxin transcripts as well as confirmed the
presence of mRNA encoding Vc1.1, a pharmacologically active
peptide identified previously in adult specimens of C. victoriae
(43). Thus, targeting different developmental stages proved to
be a powerful technique for the discovery of novel bioactive
peptides that are masked in the adult by the presence of highly
abundant transcripts. Testing the embryonic -conotoxins
against different subtypes of the neuronal nicotinic receptor
revealed that the embryonic toxin peptides had different target
specificities. The embryonic peptideVc1.2 exhibited high affin-
ity toward the 32 and 7 nAChR subtype but lower activity
toward 910, the preferred receptor subtype for Vc1.1 (52).
Little is known about the presence or distribution of the
nAChRs in invertebrates (60). In mammals, the 7 subtype is
among the most abundant nicotinic receptors (61). With an
unusually high permeability for calcium ions, this subtype reg-
ulates many calcium-dependent events throughout the central
and peripheral nervous system (61). In contrast, in mice, the
expression of the32 subtype is restricted to the habenuloint-
erpeduncular tract in the brain (62). Similarly, expression of the
910 nicotinic receptor is restricted to the cochlear hair cells,
peripheral blood lymphocytes (63), skin keratinocytes (64, 65),
and dorsal root ganglia (66, 67) where co-expression with 7
has been observed (68). Given this subtype-specific expression
pattern of the nAChRs, conotoxins that selectively antagonize
different nicotinic subtypes are likely to exhibit distinct biolog-
ical functions.
The structures of Vc1.1 and Vc1.2 were almost identical, and
changes in their target specificity were mediated by substitu-
tions of a small number of amino acid side chains, although the
disulfide scaffold was conserved (25, 55). This extraordinary
ability to generate peptides with novel neuronal activities but
equal structural stability has enabled cone snails to quickly
adapt to changes in their biotic environment and rapidly diver-
sify. Combining our findings on the structure-activity relation-
TABLE 1
Structural statistics for Vc1.2
No. of distance constraints 202
Intra-residue (i j) 105
Sequential (i j 1) 67
Short (1	 ij	 6) 29
Long 1
No. of dihedral constraints 16
Energy (kcal/mol)a
ENOE 4.1 0.6
Deviations from ideal geometryb
Bonds 0.0038 0.0002 Å
Angles 0.6980 0.0184°
Impropers 0.5730 0.0273°
Mean global R.M.S.D. (Å)c
Backbone heavy atoms (N, Ca, C) 0.66 0.19






a The values for ENOE are calculated from a square well potential with force con-
stants of 50 kcal mol1 Å2.
b The values for the bonds, angles, and impropers show the deviations from ideal
values based on perfect stereochemistry.
cMean pairwise root-mean-square deviation (R.M.S.D.) over all residues calcu-
lated in MOLMOL.
d Data are as determined by the program PROCHECK-NMR for all residues ex-
cept Gly and Pro.
FIGURE 4. Solution structure of Vc1.2. A, stereo view of the family of 20 final
structures of Vc1.2, superimposed over the backbone heavy atoms. B, stereo
ribbon view of the closest-to-average structure of Vc1.2 highlighting the
-helix and two disulfide bonds. Side chains are shown except for prolines.
C, comparison of the solution structures of Vc1.2 (pink) andVc1.1 (30) (Protein
Data Bank code 2H8S, green). Structures are superimposed over the back-
bone heavy atoms. Side chains of Vc1.1 residues important for 910 nAChR
binding (30) and equivalent residues in Vc1.2 are shown.
FIGURE 5. Alignment of -conotoxins from C. victoriae highlighting resi-
dues important for biological function. Differences in sequence between
the embryonic toxins Vc1.2 and Vc1.3 to the adult toxin Vc1.1 are shown in
green. Amino acid residues likely to have caused a loss in activity toward the
910neuronal nicotinic subtype (54), theN-type calciumchannels,3 and the
7 subtype (55) are highlighted in pink and yellow and depictedwith a frame,
respectively. The disulfide bonds between Cys1–Cys3 and Cys2–Cys4 are indi-
catedbyblack lines. Thebackbone loops formedby this disulfide connectivity
are shown below the sequences. All three C termini are likely to be amidated
(#), a commonmodification in conotoxins.
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ships of Vc1.2 and Vc1.3 with data obtained from scanning
mutagenesis studies on Vc1.1 (54),5 residues causing a shift in
target specificity can now be predicted. Amino acid substitu-
tions affecting Asp5 to Arg7 and Asp11 to Ile15 caused a signifi-
cant decrease in the affinity of Vc1.1 toward the 910 subtype
(54). Because only four of these amino acids differ between
Vc1.1 and Vc1.2, substitutions of one or more of these residues
are likely to have caused the shift in subtype specificity. Inter-
estingly, in Vc1.1, three of these side chains are charged, and
one is an imidazolium ring. In Vc1.2, all are replaced by
uncharged residues. This charge loss may contribute to the
decreased affinity of Vc1.2 for the 910 subtype. Unlike Vc1.1
and Vc1.2, Vc1.3 did not inhibit GABAB receptor/N-type Ca2
channels. Vc1.3 differs from the other two peptides in five posi-
tions, four of which are known to be important sites for GABAB
receptor recognition.5 Likewise, specific differences in amino
acids between Vc1.3 and Vc1.2 must contribute to a loss in
activity toward the 32 and 7 subtypes (51, 55).
This poses the following questions.Why do these toxins have
a different biological target than the most abundant -cono-
toxin in the adult snail? Why do cone snail embryos express
toxin-encoding mRNAs in the first place? Histological investi-
gations demonstrated that at the time of sampling, the cells of
the mid-esophagus had not yet formed the esophageal ventral
groove that will later develop into the venom gland. However, it
is possible that the cells of the incipient venom gland had begun
to hypertrophy and produce mRNA transcripts of toxin genes
prior to tissue differentiation. Embryos were harvested
approximately 2 weeks before hatching occurred. Unfortu-
nately, hatched stages could not be recovered. Morphological5 D. J. Adams and B. Callaghan, unpublished data.
FIGURE 6.Histological preparations of the adult venomapparatus and embryos of C. victoriae. Sections wereMallory-stained and cut at 7m thickness.
A, cross-section through the venomapparatus ofC. victoriae showing the venomduct (VD), the venombulb (VB), the proboscis (PB), the gill (GL), and thebuccal
mass (BM). Scale bar, 200m. B, serial sections (panels i–vi) through an embryo depicting foregut (fg), left cerebral ganglion (lcg), left pedal ganglion (lpg), left
statocyst (ls), mouth (m), mantle cavity (mc), midgut (mg), midgut opening (mgo), muscle (mu), osphradial ganglia (og), osphradium (op), right cerebral
ganglion (rcg), right cephalic tent (rct), right eye (re), radula sack (rs), right pedal ganglion (rpg), style sac (ss). The incipient venom gland is marked with an
asterisk. Scale bar, 200 m. C, schematic of the venom apparatus showing orientation of section shown in A. D, drawing of the larvae showing orientation of
serial sections shown in B.
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studies of embryos ofConus anemone showed that immediately
prior to hatching the esophageal diverticulum was filled with
secretory granules (15) likely to contain conotoxins (58).
Oocytes of some marine organisms such as sea urchins and
starfish store maternal mRNAs enabling rapid biosynthesis of
vital proteins in the developing embryo (69–71). Given that C.
anemone embryos synthesize venom granules in the incipient
venom duct tissue, toxin mRNA transcripts identified inC. vic-
toriae embryos are not likely to be of maternal origin.
Although we were unable to detect transcripts at the protein
level, it is unlikely that the embryonic toxins solely represent
silent transcripts. Electrophysiological investigations demon-
strated that the embryonic toxin Vc1.2 is active in its mature
state and combined with the presence of a variety of different
O-superfamily toxins, it indicates that embryos express func-
tionally active peptides.
Juveniles of C. pennaceus and Conus mediterraneus have
been reported to feed on small gastropods shortly after hatch-
ing (17, 72). Based on these findings, venommRNA expression
in cone snail embryos could represent preparation of the
venommachinery for a predatory lifestyle (Fig. 7B).C. victoriae
is therefore likely to hatch from the egg capsule as a short lived
nonfeeding larva or a juvenile. Similarly, mRNA encoding chy-
motrypsin-like preproprotease, a highly expressed protein in
the intestine of the adult gastropod Halotis rufescens, was
detected in amebocyte of the digestive tissue of embryos well
before metamorphosis and gut morphogenesis (73). When the
relationship between the morphogenesis and appearance of
secretory components were studied in embryos of the viper
Vipera palaestinae, neurotoxins and venom-specific enzymes
were detected by immunohistochemistry together with secre-
tion of granules into the lumen of the venom gland days before
hatching (74). As proposed for cone snails, it can be hypothe-
sized that snake embryos synthesize venom to prime for a pred-
atory lifestyle. Juveniles ofC.magus experienced an age-related
change in prey type from polychaetes to fish (19). It is now well
understood that the venom composition of fish-hunting cone
snails is different from that of mollusc and worm hunters (2).
FIGURE 7.Potential usage of toxins in cone snail embryos. A, C. victoriae guarding egg capsules. Cone snail embryosmay express toxinmRNA transcripts as
preparation for a predatory life style (B) or to deter predators (C), or toxin peptidesmaybe involved in other biological pathways such as neuronal signaling (D).
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Adult C. victoriae are molluscivorous (mollusc-eating). The
feeding behavior of juvenile C. victoriae has not been investi-
gated, but differences in toxin expression between the embryos
and the adults may indicate that similar lifestyle changes occur
in C. victoriae. Differences in the relative abundances of cono-
toxins may therefore indicate that the venom composition
undergoes ontogenetic changes as observed in other venomous
animals (75). Behavioral studies on newly hatched juveniles and
investigations on relative abundances of conotoxins at different
developmental stages are needed to further support this notion.
Cone snail embryos and newly hatched juvenilesmay synthe-
size venom for defense rather than predation (Fig. 7C). Injec-
tion of the venom into the snail’s prey causes immediate paral-
ysis (76), and thus compounds that are utilized for hunting can
also serve for defense. Anecdotal evidence for the usage of
venom in defense by adult cone snails is emerging (11). Synthe-
sis of defensive or deterrent compounds is a common phenom-
enon in embryos and larvae of many marine organisms (77–
80). Defensive compounds include glycosides (79), alkaloids
(81), cyclic peptides (82), halogenated phenols (80), and ter-
penes (77). Interestingly, comparisons between adult and larval
deterrent profiles revealed that the same compounds are uti-
lized by different life stages, but concentrations can vary exten-
sively (78, 80, 82). In cone snails, full development of the venom
apparatus occurs during or shortly after hatching (16, 17, 72). It
can be hypothesized that juveniles of C. victoriae inject the
novel embryonic toxins into their prey and potential predators/
competitors. Consequently, changes in the venom repertoire
may reflect differences in the type of predators and competitors
with which these animals interact.
It is now well understood that most toxins are proteins that
have originally been recruited from ancestral body proteins
through gene duplication and subsequent mutation and/or
deletion events (83). The three-dimensional scaffold of the
newly generated toxin multigene family is generally preserved,
although the remaining residues diversify to generate mole-
cules with novel biological activities (83). For example, the
snake three-finger neurotoxins are derivations of endogenous
neuropeptides similar to a family of proteins found in humans,
the SLUR proteins (84). SLUR proteins therefore belong to a
group of toxin-like proteins with nontoxin endogenous activi-
ties. For example, SLURP-1 is a disulfide-rich endogenous
ligand of the7 nicotinic receptor subtype (85) and is expressed
in a varietyofdifferent tissue types, including skin, gums, stomach,
and the esophagus (86). The bee -conotoxin-like protein 1
(OCLP1) isanotherexampleofa toxin-likepeptide thatpotentially
represents an ancestral toxin protein (87). OCLP1 exhibits the
characteristic disulfide scaffold of cone snail -conotoxins and is
highly expressed in the bee brain where it has been suggested to
modulate voltage-gated Ca2 channel activity (87).
As whole embryos were taken for molecular sequencing,
toxin transcripts might have originated from tissues other than
the incipient venom gland. The embryonic peptides could there-
fore represent toxin-like compounds that function as endogenous
neuronal modulators in the developing snail embryo (Fig. 7D).
Sequencingandphylogenetic analysisof toxinsand toxin-likepep-
tides from the venom gland and tissues not involved in venom
biosynthesis could be revealing in this context.
In summary, this study has identified novel - and O-toxin
peptides in embryos of the cone snail C. victoriae. Embryonic
-conotoxins differ significantly in their biological function
from themost abundant -conotoxin in the adult, although the
three-dimensional structure is conserved. We suggest that the
venomof cone snails undergoes ontogenetic variations and that
the early onset of venom expression in embryos most likely
represents preparation for predation and/or defense, although
a role in endogenous processes cannot be ruled out. Future
analyses of embryos from additional mating events will be
informative in this context. Behavioral studies and further
characterization of the venom composition in embryos and
adult snails will provide insights into the mechanisms underly-
ing the generation of biodiversity in Conus.
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Note Added in Proof—Since our manuscript was accepted, we have
learned of some earlier studies that have shown embryonic toxin
expression in sea anemones (88, 89) and Hydra embryos (90).
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Supplemental Table 1. Sequences of oligonucleotides used in this study 
 
Gene Oligonucleotide Sequence 5’-3’ Reference 
universal             
α-conotoxin-1 
RT-PCR F-ATGGGCATGCGGATGATGTT                      
R-CGGAAAGTGAAGCAGGTCAG 
Sandall et al. 
2003 (1) 
universal             
α-conotoxin-2 
RT-PCR F- TCTGCGAATGGGCATGCGGATGATGTT 
R- TGCTCCAACGTCGTGGTTCAGAGGGTC 
Lopez-Vera et al. 
2007 (2) 
universal             
α-conotoxin-3 
RT-PCR F- TCTGATGGCAGGAATGACGCAG 
R- TCGTGGTTCAGAGGGTCCTGG 




RT-PCR F- AGCCTTGAAGTCTCTGAAGA 
R- GACCCTGCCG TCATCTCAGC 
Zhangsun et al 
2006 (4) 
Vc1.1 nested RT-PCR F-TGCCGCAGCCAAAGC                           
R-TTTCTGGATGATCATAGT 
DD122895 a 
Vc1.2 nested RT-PCR F-CTCTGACCATCAAGG                           
R-CTGTGGATTATTCACCA 
GU046308 a 




a GenBank (http://www.ncbi.nlm.nih.gov) nucleotide accession number 





Supplemental Figure 1. Nested reverse transcription (RT)-PCR showing that Conus victoriae 
embryos express Vc1.1, an α-conotoxin initially sequenced from adult specimens. Nested RT-
PCR further revealed cDNA expression of the novel embryonic α-conotoxin Vc1.2 in adult 
snails. RT-PCR was performed on 110 ng of larval and adult cDNA (pooled larvae n=2, adult 
n=2) using the universal α-conotoxin oligonucleotides and 3 uL of the 1:5 diluted PCR 
reaction was used as a template for nested PCR. Negative PCR controls were performed with 
RT reactions from which the enzyme reverse transcriptase was excluded (nRT). Nested PCR 
amplifications were analysed by gel electrophoresis (A) and subjected to nucleotide 
sequencing. DNA ladder: 1 kb plus (Invitrogen). (B) Protein sequences of toxin precursors 






Supplemental Figure 2. Amide and aromatic region of 1D 1H-NMR spectra of Vc1.2 at 5 °C 
intervals from 5 to 25 °C at pH 3.2 (acquired on a DRX-600 spectrometer) and pH 5.5 
(acquired on a Avance-800 spectrometer). The amide proton peak of Cys2 is labeled, which 






Supplemental Figure 3. The solution structure of Vc1.2 (pink) is superimposed with the 
crystal structure of PInA ((5), PDB 1PEN, blue) over the backbone heavy atoms. Pro6 and 
Pro7 in PInA and equivalent residues in Vc1.2 (Pro6 and Ala7) are shown. These prolines do 
not affect the formation of the helical secondary structures.  
 
 
Supplemental Figure 4. Identification of multiple analogues of the α-conotoxin Vc1.1 in the 
venom of Conus victoriae by reversed-phase liquid chromatography (A) and subsequent mass 
spectrometric analyses (B) Venom was fractionated on a C18 column (Waters) using a linear 
gradient from 10 to 60% buffer B [95 % acetonitrile (ACN) / 0.1% TFA, buffer A: 0.1 % 
TFA] over 70 min. Reversed-phase fractions were collected and analysed on a MALDI-TOF 
mass spectrometer (QSTAR Pulsar, AB SCIEX). Multiple analogues of Vc1.1 were observed 
(B), the simplest being the toxin containing four disulfide bonds and a C-terminal amidation. 
Additional posttranslational modifications include hydroxylation of Pro6 and Pro13 and γ-
carboxylation of Glu14. The embryonic peptides Vc1.2 and Vc1.3 could not be detected in 
the venom of C. victoriae using a variety of different mass spectrometric techniques. 
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